Telix Pharmaceuticals Ltd. (TLX)
8.96
+0.10
(+1.19%)
USD |
NASDAQ |
Nov 18, 16:00
8.955
0.00 (0.00%)
After-Hours: 20:00
Telix Pharmaceuticals EPS Diluted (Quarterly)
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 0.0356 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Mesoblast Ltd. | -- |
| Immutep Ltd. | -- |
| CSL Ltd. | -- |
| Ceryvyn Therapeutics Ltd. | -- |
| Propanc Biopharma, Inc. | -12.22 |
EPS Diluted (Quarterly) Related Metrics
| Enterprise Value | 2.977B |
| Earnings Yield | 1.04% |
| Normalized Earnings Yield | 0.6094 |